2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | CA$1.2B | CA$2.2B | CA$3.7B | CA$2.2B | CA$2.1B |
Cost of Revenue | CA$815M | CA$905M | CA$1.1B | CA$1.1B | CA$954M |
Gross Profit | CA$433M | CA$1.3B | CA$2.6B | CA$1.1B | CA$1.1B |
Gross Profit % | 35% | 59% | 70% | 51% | 54% |
R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 | CA$0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -CA$1.5B | CA$1.1B | CA$1.3B | -CA$238M | -CA$47M |
Dep. & Amort. | CA$2.3B | -CA$485M | CA$577M | CA$1.9B | CA$0 |
Def. Tax | -CA$374M | CA$187M | CA$289M | -CA$190M | -CA$38M |
Stock Comp. | CA$43M | CA$42M | CA$44M | CA$43M | CA$16M |
Chg. in WC | CA$12M | -CA$57M | CA$217M | -CA$61M | -CA$183M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | CA$6.9M | CA$6M | CA$14M | CA$141M | CA$132M |
ST Investments | CA$127K | CA$127K | CA$135K | CA$0 | CA$0 |
Cash & ST Inv. | CA$6.9M | CA$6M | CA$14M | CA$141M | CA$132M |
Receivables | CA$196M | CA$329M | CA$374M | CA$243M | CA$298M |
Inventory | CA$13M | CA$20M | CA$20M | CA$57M | CA$41M |
Production averaged 84,543 BOE/day in 2024, with international production up 12% year-over-year, while North American production declined by 5%.
Generated $1.2 billion in fund flow ($7.63/share) and $583 million in free cash flow ($3.69/share), representing a 9% increase over 2023 on a per-share basis.
Successfully executed a $623 million E&D capital program, including investments in Germany, Croatia, and the Montney asset, expected to contribute strong free cash flow in future years.
Announced an 8% increase to the quarterly dividend effective Q1 2025, marking the fourth consecutive increase since reinstating the dividend.
Provided 2025 guidance with annual production expected between 125,000-130,000 BOE/day and E&D capital expenditures of $730-$760 million, forecasting $400 million in free cash flow for the year.